Orthofix completes $157.5M sale of sports medicine unit; ConforMIS' knee replacement system wins industry award;

 @FierceMedDev: The Senate passed the FDA user fee bill 96-1, a move praised by members of the device industry. Story | Follow @FierceMedDev

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

> The deal is done. Orthofix International ($OFIX) has completed the $157.5 million sale of its Breg sports medicine unit to Water Street Healthcare Partners. Release

> Fenwal obtained Canadian regulatory approval for its Aurora plasmapheresis system, a device designed to collect plasma from blood donors. Release

> Vibrynt, a startup making a new obesity treatment device, has raised half of a $5.5 million offering, MedCity News reports. Story

> The Minnesota company Uroplasty ($UPI) will begin testing its neuromodulation treatment for overactive bladders as a treatment for fecal incontinence in a trial set to begin this summer, MedCity News reports. Story

> Cepheid ($CPHD) gained FDA clearance to use its new GeneXpert Infinity-80 system to process its flu molecular diagnostic test. Release

> Sensor-augmented insulin pump therapy with a low-glucose suspend function looks to be safe for patients with Type 1 diabetes, according to a new study. Blog

> Israeli device company Medigus gained FDA clearance for its SRS Endoscopic system, which is designed to treat gastroesophageal reflux disease. Story

Biotech News

 @FierceBiotech: FDA panel mixed on Pfizer's rare disease drug. More | Follow @FierceBiotech

 @RyanMFierce: Bloomberg: After dubious Sirtris deal, Glaxo has targeted partners in recent M&As. Report | Follow @RyanMFierce

 @JohnCFierce: EMA recommends Vertex's Kalydeco for cystic fibrosis population. Item | Follow @JohnCFierce

> Elan boss: Climate improved for Alzheimer's drugs. Article

> Sangart stashes $50M funding for oxygenation drugs. News

> GSK gambles on biotech partners after dubious M&A deal. More

Pharma News

 @FiercePharma: Watson asks for FDA approval on generic Testim, Auxilium's testosterone drug. Auxilium sues (of course). Story | Follow @FiercePharma

> House could vote on FDA bill next week. Report

> EMA continues Pradaxa support but wants clearer warnings. Article

> Takeda takes buying binge into Brazil with $265M Multilab deal. Item

> Ranbaxy brings in U.S. consultants as part of consent decree. News

And Finally... ConforMIS says its iTotal CR knee replacement system won the silver medal in the "Implant and Tissue-Replacement Products" category for the 2012 Medical Design Excellence Awards. Release

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

Drug-pricing watchdog ICER has partnered with medical data firm Aetion to help analyze the real-world performance of different treatments.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.